Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

5 May 2011 07:00

RNS Number : 9726F
Tarsus Group PLC
05 May 2011
 



 

5 May 2011

 

 

TARSUS GROUP plc

 

Interim Management Statement

 

On track for the full year - forward bookings accelerating

 

Tarsus Group Plc ("Tarsus" or "the Group"), the international business-to-business media group, is today publishing its Interim Management Statement relating to the period from the publication of its Preliminary Results on 7 March 2011 to 5 May 2011.

 

Trading Performance

 

Trading for the period and forward bookings for the full year have been positive and remain in-line with the Board's expectations. A summary of major developments includes:

 

§ US

 

As previously indicated the February 2011 Off-Price Show in Las Vegas performed well with revenues up 10%. The broadening of the offer to retailers by the inclusion of footwear and accessories has been a major factor in this division's success. Bookings for the August show are good.

 

The Medical division demonstrated good growth driven by our education programmes including those now delivered online. There have been a number of events in the period the largest of which was the April Orlando event which produced revenues 2% ahead of last year. This division continues to grow its total revenues at a double digit rate.

 

§ France

 

The trends that we experienced in the second half of 2010 continued into the first 4 months of 2011 with the portfolio stabilising. Mod'amont, our largest event in the period, was the same size as its February 2010 edition and was well received by our customers with a good increase in visitors. The smaller IT and services exhibitions in April produced revenues behind last year's editions but, encouragingly for the future, grew their attendances by 8%.

 

§ Emerging Markets

 

Our Emerging Markets business continued to gain momentum with strong revenue growth. In the period, we held a number of events in the Middle East which all demonstrated good performances and, very encouragingly, across the board attendances at these events were well ahead of their previous editions.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Preliminary Results on 7 March 2011.

 

Outlook

 

We remain committed to our long term strategy of increasing our exposure to Emerging Markets (Project 50/13) and driving organic growth within the business. Activity in the exhibition market generally is picking up and we are seeing an increase in M&A opportunities which fit our criteria.

 

Within each two-year cycle, odd years are by far the larger in profit terms for the Group as they contain both Labelexpo Europe (in September) and the Dubai Airshow (in November). Bookings for Labelexpo Europe continue to improve and are now tracking over 10% up on its previous edition. The Dubai Airshow bookings are tracking in-line with its previous edition.

 

As in previous years, the Group's revenues remain heavily second-half weighted. Forward bookings continue to accelerate and now stand at 75% of anticipated full year revenues compared with 67% at the same time in 2010 (as adjusted for biennial events).

 

 

 

 

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

 

Media:

 

Madano Partnership

Matthew Moth 020 7593 4000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKQDPCBKDPPK
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBlock Listing Six Monthly Return
9th May 20187:00 amRNSBoard Changes
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.